, Praveen Kumar (Co-founder & CEO)_Neuranics_20241206141000_original_image_8.webp)
The funding will be used to advance technology development, and clinical validation, and prepare the company for commercial production post-CDSCO licensing
Read More
The collaboration focuses on conducting validation studies on Trucan's next-generation cancer diagnostic tests, which leverage advanced techniques such as next-generation sequencing and biomarker-driven diagnostics
Read More
AGI is considered a transformative technology with significant potential, particularly in revolutionising healthcare
Read More
Gut health is emerging as a major concern in India, where 7 out of 10 individuals suffer from issues like constipation, indigestion, and acidity. With the global gut health market projected to reach USD 18 billion by 2025–26
Read More_20241016185155_original_image_38.webp)
To commemorate the occasion, MedGenome has released a corporate video titled 10 Years of Pioneering Genomics
Read More_20241003113409_original_image_24.webp)
The partnership, following Agilus’ brand identity relaunch in 2023, aims to enhance customer engagement and strengthen the company’s position as a leader in advanced diagnostic services across the country
Read More
The funding was led by Denmark's Investment Fund for Developing Countries (IFU) with a commitment of USD 20 million, alongside existing investors LeapFrog Investments (USD 15 million), HealthQuad, and Spark Growth Ventures
Read More
lightspeed Venture Partners is set to lead a $50-60 million funding round for Qure.ai, an AI-driven provider of diagnostic imaging support tools.
Read More
MPOX, a highly contagious viral disease known for its potential to trigger localised outbreaks, poses a serious threat to public health if not managed effectively
Read More
Cloud technology is at the forefront of this transformation, enabling healthcare and pharmaceutical SMEs to navigate the challenges of an ever-evolving landscape
Read More
